Tag: allergy immunotherapy market segments

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Allergy Immunotherapy Market Size Changed, over the years?

The market of allergy immunotherapy has experienced a significant expansion in the past few years. From $2.88 billion in 2024, it’s projected to rise to $3.17 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. Factors contributing to its growth over the historical period include a surge in allergic disease cases, advances in immunotherapy methods, heightened patient awareness, government support, and enhancements in research and development.

How Much Will the Allergy Immunotherapy Market Be Worth in 2029?

The market size for allergy immunotherapy is predicted to see a swift expansion in the coming years. It is projected to grow to $5.07 billion in 2029, witnessing a compound annual growth rate (CAGR) of 12.4%. The growth anticipated in this forecast period is due to various factors like the increasing global allergy load, supportive healthcare policies, growing acceptance of immunotherapy, emergence of new markets and untapped regions, and a rise in healthcare expenditure. Notable trends in the forecast period encompass progress in treatment technology, escalating prevalence of allergies, increasing patient awareness, and education efforts, telemedicine, remote monitoring, and personalized treatment plans.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

Which is the Largest Company in the Allergy Immunotherapy Market?

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

What Are the Main Market Drivers in the Allergy Immunotherapy Industry?

The allergy immunotherapy market is expected to witness significant growth, primarily due to the increasing incidence of allergic disorders. These disorders are characterized by exaggerated immune reactions to specific antigens. Autoimmune diseases, on the other hand, occur when the immune system mistakenly attacks the body’s own parts. Allergy immunotherapy is typically administered to atopic individuals suffering from allergy disorders such as IgE-mediated allergic rhinitis and allergic asthma induced by inhaled allergens like pollens and house dust mites (HDMs). For example, as reported by the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency, in August 202, English hospitals in 2022-23 had over 25,000 admissions related to allergies and anaphylaxis, a figure which is more than double the number seen in the past two decades. In another report published by the Food Standards Agency, a UK-based government body, in May 2024, it stated that around 6% of UK adults, equivalent to approximately 2.4 million individuals, suffer from food allergies, as revealed by the Patterns and Prevalence of Adult Food Allergy (PAFA) report. Therefore, this surge in allergic disorders is a primary driver for the expansion of the allergy immunotherapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smp

How Is the Allergy Immunotherapy Market Segments Structured?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

What Strategic Trends Are Transforming the Allergy Immunotherapy Market?

Leading corporations in the allergy immunotherapy market are utilizing innovative technological products, such as the allergy component testing powered by artificial intelligence (AI), to maintain their market standing. The AI-powered allergy component testing is a cutting-edge testing platform that uses component resolved diagnostics (CRD) for identifying various types of allergies. For example, Metropolis Healthcare Limited, a medical laboratory company based in India, launched its AI-powered allergy component testing in May 2023. This fourth-generation allergy testing technology leverages AI to aid clinicians in making medical decisions. It offers valuable insights, which help in selection and optimization of treatment plans for allergic diseases. Additionally, it has the ability to predict the success of immunotherapy for allergy vaccinations.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Global Regions Offer the Highest Growth in the Allergy Immunotherapy Market?

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416

This Report Delivers Insight On:

1. How big is the allergy immunotherapy market, and how is it changing globally?

2. Who are the major companies in the allergy immunotherapy market, and how are they performing?

3. What are the key opportunities and risks in the allergy immunotherapy market right now?

4. Which products or customer segments are growing the most in the allergy immunotherapy market?

5. What factors are helping or slowing down the growth of the allergy immunotherapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Allergy Immunotherapy Market Size Changed, over the years?

The market of allergy immunotherapy has experienced a significant expansion in the past few years. From $2.88 billion in 2024, it’s projected to rise to $3.17 billion in 2025, boasting a compound annual growth rate (CAGR) of 10.2%. Factors contributing to its growth over the historical period include a surge in allergic disease cases, advances in immunotherapy methods, heightened patient awareness, government support, and enhancements in research and development.

How Much Will the Allergy Immunotherapy Market Be Worth in 2029?

The market size for allergy immunotherapy is predicted to see a swift expansion in the coming years. It is projected to grow to $5.07 billion in 2029, witnessing a compound annual growth rate (CAGR) of 12.4%. The growth anticipated in this forecast period is due to various factors like the increasing global allergy load, supportive healthcare policies, growing acceptance of immunotherapy, emergence of new markets and untapped regions, and a rise in healthcare expenditure. Notable trends in the forecast period encompass progress in treatment technology, escalating prevalence of allergies, increasing patient awareness, and education efforts, telemedicine, remote monitoring, and personalized treatment plans.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

Which is the Largest Company in the Allergy Immunotherapy Market?

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

What Are the Main Market Drivers in the Allergy Immunotherapy Industry?

The allergy immunotherapy market is expected to witness significant growth, primarily due to the increasing incidence of allergic disorders. These disorders are characterized by exaggerated immune reactions to specific antigens. Autoimmune diseases, on the other hand, occur when the immune system mistakenly attacks the body’s own parts. Allergy immunotherapy is typically administered to atopic individuals suffering from allergy disorders such as IgE-mediated allergic rhinitis and allergic asthma induced by inhaled allergens like pollens and house dust mites (HDMs). For example, as reported by the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency, in August 202, English hospitals in 2022-23 had over 25,000 admissions related to allergies and anaphylaxis, a figure which is more than double the number seen in the past two decades. In another report published by the Food Standards Agency, a UK-based government body, in May 2024, it stated that around 6% of UK adults, equivalent to approximately 2.4 million individuals, suffer from food allergies, as revealed by the Patterns and Prevalence of Adult Food Allergy (PAFA) report. Therefore, this surge in allergic disorders is a primary driver for the expansion of the allergy immunotherapy market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smp

How Is the Allergy Immunotherapy Market Segments Structured?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

What Strategic Trends Are Transforming the Allergy Immunotherapy Market?

Leading corporations in the allergy immunotherapy market are utilizing innovative technological products, such as the allergy component testing powered by artificial intelligence (AI), to maintain their market standing. The AI-powered allergy component testing is a cutting-edge testing platform that uses component resolved diagnostics (CRD) for identifying various types of allergies. For example, Metropolis Healthcare Limited, a medical laboratory company based in India, launched its AI-powered allergy component testing in May 2023. This fourth-generation allergy testing technology leverages AI to aid clinicians in making medical decisions. It offers valuable insights, which help in selection and optimization of treatment plans for allergic diseases. Additionally, it has the ability to predict the success of immunotherapy for allergy vaccinations.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Global Regions Offer the Highest Growth in the Allergy Immunotherapy Market?

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416

This Report Delivers Insight On:

1. How big is the allergy immunotherapy market, and how is it changing globally?

2. Who are the major companies in the allergy immunotherapy market, and how are they performing?

3. What are the key opportunities and risks in the allergy immunotherapy market right now?

4. Which products or customer segments are growing the most in the allergy immunotherapy market?

5. What factors are helping or slowing down the growth of the allergy immunotherapy market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Discover trends, market shifts, and competitive outlooks for the allergy immunotherapy industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#How Has The Allergy Immunotherapy Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The scale of the allergy immunotherapy market has expanded swiftly in the past few years. It is anticipated that the market will escalate from a value of $2.88 billion in 2024 to $3.17 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. The progression observed in the historic duration can be credited to the rise in allergic diseases occurrences, enhancements in immunotherapy treatments, intensified consciousness among sufferers, initiatives by the government, and improvements in the field of research and development.

The market size for allergy immunotherapy is forecasted to witness swift expansion in the forthcoming years, achieving a value of $5.07 billion in 2029 and growing at a compound annual growth rate (CAGR) of 12.4%. The factors contributing to the anticipated growth during this forecast period include a growing global allergy load, healthcare policy support, the increased adoption of immunotherapy, the development of emerging markets and unexplored areas, and a rise in healthcare spending. Predominant trends foreseen within this period are advancements in treatment technology, escalating allergy incidence, an increase in patient awareness and education, the use of telemedicine and remote monitoring, and the implementation of personalized treatment plans.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

What Are the Primary Drivers Supporting the Market Growth of the Allergy Immunotherapy Market?

The increase in allergic disorders is anticipated to spur the expansion of the allergy immunotherapy market. Allergic disorders denote overreactive immune responses to specific antigens. Misdirected immune responses against the body’s own parts lead to autoimmune diseases. Allergy immunotherapy is accessible for atopic individuals suffering from allergy disorders such as IgE-mediated allergic rhinitis and allergic asthma caused by inhaled allergens, such as pollens and house dust mites. In August 202, the UK’s Medicines and Healthcare Products Regulatory Agency reported that, in 2022-23, English hospitals saw over 25,000 admissions due to allergies and anaphylaxis, more than double the number seen in the previous two decades. Furthermore, in May 2024, the Food Standards Agency in the UK issued the Patterns and Prevalence of Adult Food Allergy (PAFA) report, stating that around 6% of adults in the UK, roughly 2.4 million people, are affected by food allergies. Hence, the increasing occurrence of allergic disorders is fueling the growth of the allergy immunotherapy market.

Which Primary Segments of the Allergy Immunotherapy Market Are Driving Growth and Industry Transformations?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smp

Which Regions Are Key Players in the Growth of the Allergy Immunotherapy Market?

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Are the Most Significant Market Trends in the Allergy Immunotherapy Market?

Key players in the allergy immunotherapy market are incorporating technological advancements, such as artificial intelligence (AI)-powered allergy component testing, thus ensuring their sustained market standing. This groundbreaking testing platform, which takes advantage of component resolved diagnostics (CRD), facilitates the diagnosis of various types of allergies. For example, in May 2023, Metropolis Healthcare Limited, a medical laboratory company based in India, introduced its take on this AI-powered allergy testing apparatus. This advanced technology, representing the fourth-generation of allergy testing, employs artificial intelligence (AI) to aid clinicians in their clinical decision-making. It delivers significant insights while also selecting and fine-tuning the treatment pathway for allergic diseases. Furthermore, this tool is able to predict whether immunotherapy for allergy vaccinations will be effective.

View the full report here:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

What Parameters Are Used to Define the Allergy Immunotherapy Market?

Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

What Major Innovations Are Driving the Accelerated Growth of the Allergy Immunotherapy Market?

The increasing occurrence of allergic conditions is anticipated to stimulate the expansion of the allergy immunotherapy market in the future. Allergic conditions are characterized by overzealous immune reactions to particular antigens, and misguided immune responses against the body’s own internal components lead to autoimmune diseases. Allergy immunotherapy provides relief for atopic individuals suffering from allergy disorders such as IgE-mediated allergic rhinitis and allergic asthma caused by inhaled allergens like pollen and house dust mites (HDMs). For example, in August 202, the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based executive agency, reported that English hospitals faced over 25,000 admissions for allergic episodes and anaphylaxis in 2022-23, which is more than double the number from the previous two decades. Furthermore, the Food Standards Agency, a UK government department, stated in May 2024 in their Patterns and Prevalence of Adult Food Allergy (PAFA) report that roughly 6% of UK adults, or around 2.4 million people, suffer from food allergies. Consequently, this growing rate of allergic conditions is spurring the progression of the allergy immunotherapy market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

#How Will the CAGR of the Allergy Immunotherapy Market Influence Its Overall Growth by 2034?

In the past few years, the size of the allergy immunotherapy market has seen swift expansion. Expect to observe an increase from $2.88 billion in 2024 to $3.17 billion in 2025, showing a compound annual growth rate (CAGR) of 10.2%. The historic rise can be credited to a higher prevalence of allergic diseases, advancements in immunotherapy methods, increased patient awareness, governmental efforts, and enhancements in research and development.

Projected to witness a significant surge in the upcoming years, the allergy immunotherapy market is set to expand to a worth of $5.07 billion by 2029, with a compound annual growth rate of 12.4%. The escalation anticipated during this period is linked to factors such as the escalating global burden of allergies, supportive healthcare policies, growing acceptance of immunotherapy, emergence of new markets and unexplored regions, and increased healthcare spending. The period also forecasts trends like the evolution in treatment technology, heightened prevalence of allergies, increased patient awareness and education, implementation of telemedicine and remote monitoring, and personalization of treatment regimens.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416

What Are the Most Significant Market Trends Transforming theAllergy Immunotherapy Market?

Significant businesses in the allergy immunotherapy market are introducing advanced technology products, such as allergy component testing powered by artificial intelligence (AI), to maintain their market dominance. This innovative testing platform, armed with AI, is a component-resolved diagnostics (CRD) technique for diagnosing varied types of allergies. For instance, Metropolis Healthcare Limited, a medical laboratory company based in India, rolled out AI-driven allergy component testing in May 2023. This fourth-gen allergy testing technology employs AI to support clinicians in making clinical judgements, offering detailed insights to choose and perfect the treatment plan for allergic diseases. Additionally, it can predict the success of immunotherapy for deciding the effectiveness of allergy vaccinations.

What Are the Top Market Players Propelling the Growth of theAllergy Immunotherapy Industry?

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Primary Segments of the Allergy Immunotherapy Market Are Driving Growth and Industry Transformations?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=9416&type=smpGlobal Allergy Immunotherapy Market, Global Allergy Immunotherapy Market Report, Global Allergy Immunotherapy Market Trends, Global Allergy Immunotherapy Market Size

Browse Through More Reports Similar to the Gobal Allergy Immunotherapy Maret 2025, By The Business Research Company:

Defibrillator Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Convalescent Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What fueled the previous growth in the allergy immunotherapy market?

There’s been a swift expansion in the size of the allergy immunotherapy market in the recent past. The market, set to grow from $2.88 billion in 2024 to $3.17 billion in 2025, forecasts a compound annual growth rate (CAGR) of 10.2%. Factors such as the rising frequency of allergic ailments, advancements in immunotherapy procedures, enhanced patient awareness, government policies, and advancements in research and development have all contributed to the accelerated growth in the historical period.

What will be the allergy immunotherapy market size in the future?

The market for allergy immunotherapy is predicted to expand quickly in the coming years, reaching a value of $5.07 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 12.4%. Factors contributing to this growth during the forecast period are the escalating global allergy burden, supportive healthcare policies, growing acceptance of immunotherapy as well as emerging and untapped markets, and escalating healthcare spending. The forecast period is likely to see trends such as advancements in treatment methodologies, a surge in allergy incidence, the enhancement of patient awareness and education, utilization of telemedicine and remote monitoring, and the development of personalized treatment plans.

Get your allergy immunotherapy market report here!

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

What main drivers are fueling expansion in the allergy immunotherapy market?

With the surge in allergic disorders, the allergy immunotherapy market is expected to see significant growth. Allergic disorders are typically extreme immune responses to certain antigens. When immune responses mistakenly target the body’s own components, this can result in autoimmune diseases. Allergy immunotherapy is a treatment option for those with allergy disorders such as IgE-mediated allergic rhinitis and allergic asthma, which are caused by environmental allergens like pollen and house dust mites. For instance, according to the Medicines and Healthcare Products Regulatory Agency (MHRA), a UK-based regulatory body, English hospitals in August 202 saw over 25,000 admissions due to allergies and anaphylaxis, which was over double the number recorded in the previous two decades. Additionally, the Food Standards Agency, a UK governmental department, published a report in May 2024 indicating that around 6% of adults in the UK, or roughly 2.4 million people, were affected by food allergies according to the Patterns and Prevalence of Adult Food Allergy (PAFA) report. The escalating prevalence of such allergic disorders is thus powering the expansion of the allergy immunotherapy market.

What key areas define the segmentation of the global allergy immunotherapy market?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

Who are the dominant players expanding their reach in the allergy immunotherapy market?

Major companies operating in the allergy immunotherapy market include LETI Pharma, Stallergenes Greer International AG, Allergy Therapeutics plc, ALK-Abelló A/S, HAL Allergy B.V., DBV Technologies, Circassia Pharmaceuticals Inc., Jubilant HollisterStier LLC, Allergopharma GmbH & Co. KG, Biomay AG, Anergis SA, HollisterStier Allergy, Mylan N.V., Adamis Pharmaceuticals Corporation, Desentum Oy, WOLW Pharma Limited, AllerGenics Inc., Greer Laboratories Inc., Aimmune Therapeutics Inc., Reliant Laboratories Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Danaher Corporation, QIAGEN NV, Merck & Co. Inc., Pfizer Inc., Novartis AG, GlaxoSmithKline plc, AstraZeneca plc, Sanofi SA, Teva Pharmaceutical Industries Ltd., Endo Pharmaceuticals Inc., Sun Pharmaceutical Industries Ltd., Cipla Ltd.

How are evolving market trends shaping allergy immunotherapy Strategies?

In the allergy immunotherapy market, leading companies are embracing technological innovations, such as artificial intelligence (AI)-based allergy component testing, to maintain their market standing. This AI-driven component testing is a state-of-the-art diagnostic platform used to discern various types of allergies using component resolved diagnostics (CRD). For example, Metropolis Healthcare Limited, a medical laboratory based in India, launched an AI-powered allergy component testing platform in May 2023. This platform, a fourth-generation allergy testing technology, leverages AI assistance for physicians in clinical decision making. It offers profound insights, assists in selection, and optimizes the treatment plan for allergic ailments. Moreover, it possesses the ability to predict the efficacy of immunotherapy for different allergy vaccinations, indicating their effectiveness or inadequacy.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9416

Which regions are emerging as leaders in the allergy immunotherapy market?

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Defibrillator Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Convalescent Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How Will the Growth Rate of the Allergy Immunotherapy Market Shape Industry Trends by 2034?

In recent times, there has been a swift expansion in the size of the allergy immunotherapy market. This market is projected to swell from $2.88 billion in 2024 to $3.17 billion in 2025, with a compound annual growth rate (CAGR) of 10.2%. Factors that have contributed to the rise in the historical time frame include increased prevalence of allergies, technological advancements in immunotherapy, heightened patient awareness, various government endeavours, and enhancements in research and development.

In the coming years, substantial expansion is forecasted in the allergy immunotherapy market, with the market size expected to reach $5.07 billion by 2029, growing at a compound annual growth rate (CAGR) of 12.4%. Factors contributing to this projected growth include a rising global allergy burden, supportive healthcare policies, growing acceptance of immunotherapy, emerging markets coupled with unexploited regions, and an increment in healthcare expenditure. The forecast period is set to see a trend in advancements in treatment technology, an increasing prevalence of allergies, a boost in patient awareness and education, expansion of telemedicine and remote monitoring, as well as personalized treatment plans.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the allergy immunotherapy Market?

The increasing occurrence of allergic conditions is forecasted to boost the allergy immunotherapy market’s expansion. These conditions involve overactive immune responses to certain antigens, and misguided immune reactions to one’s own body parts lead to autoimmune illnesses. Allergy immunotherapy is provided to atopic individuals afflicted by allergy conditions like IgE-mediated allergic rhinitis and allergic asthma induced by inhaled allergens such as pollens and house dust mites (HDMs). For instance, in August 202, the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) reported that English hospitals noted over 25,000 allergy and anaphylaxis admissions in 2022-23, which is more than double the instances in the last two decades. Furthermore, in May 2024, the UK’s Food Standards Agency revealed in the Patterns and Prevalence of Adult Food Allergy (PAFA) report that roughly 6% of UK adults, approximately 2.4 million people, suffer from food allergies. Hence, the escalating frequency of allergic disorders is facilitating the growth of the allergy immunotherapy market.

Request Your Free Allergy Immunotherapy Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9416&type=smp

Who Are the Key Market Players Influencing the Growth of the Allergy Immunotherapy Industry?

Major companies operating in the allergy immunotherapy market include:

• LETI Pharma_x000D_

• Stallergenes Greer International AG_x000D_

• Allergy Therapeutics plc_x000D_

• ALK-Abelló A/S_x000D_

• HAL Allergy B.V._x000D_

What Key Market Trends Are Shaping the Future of the Allergy Immunotherapy Industry?

Leading businesses in the allergy immunotherapy market are introducing technologically advanced products, such as allergy component testing powered by artificial intelligence (AI), to maintain their market dominance. AI-powered allergy component testing is an innovative platform that leverages component resolved diagnostics (CRD) for identifying various allergy types. For example, in May 2023, Metropolis Healthcare Limited, a medical laboratory company based in India, introduced its AI-powered allergy component testing. This fourth-generation allergy testing technology employs AI to help medical experts with their clinical decision-making process. AI-powered allergy component testing provides comprehensive insights, helps in the selection, and fine-tunes the treatment pathways for allergy-related diseases. Furthermore, it possesses the ability to predict the success of immunotherapy for allergy vaccines, determining their efficacy.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/allergy-immunotherapy-global-market-report

Which Market Segments Are Driving Strategic Growth and Trends in the Allergy Immunotherapy Market?

The allergy immunotherapy market covered in this report is segmented –

1) By Allergy Type: Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy, Other Allergy Types

2) By Treatment: Subcutaneous Immunotherapy (SCIT), Sublingual Immunotherapy, Specific Immunotherapy (SIT)

3) By Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Allergic Rhinitis: Seasonal Allergic Rhinitis, Perennial Allergic Rhinitis

2) By Asthma: Allergic Asthma, Non-Allergic Asthma

3) By Food Allergy: Peanut Allergy, Tree Nut Allergy, Milk Allergy, Egg Allergy, Other Food Allergies

4) By Venom Allergy: Insect Sting Allergy, Other Venom Allergies

5) By Other Allergy Types: Allergic Conjunctivitis, Eczema, Drug Allergies, Other Environmental Allergies

Which Regions Are Emerging as Leaders in the Allergy Immunotherapy Market?

Europe was the largest region in the allergy immunotherapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the allergy immunotherapy market report during the forecast period. The regions covered in the allergy immunotherapy market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Allergy Immunotherapy Market?

Allergy immunotherapy refers to a type of therapy used to avoid allergic reactions to things like house dust mites, grass pollen, and bee venom. Immunotherapy includes giving the patient increasingly higher dosages of the chemical or allergen they are allergic to.

Browse Through More Similar Reports By The Business Research Company:

Defibrillator Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/defibrillator-devices-and-equipment-global-market-report

Convalescent Plasma Therapy Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/convalescent-plasma-therapy-global-market-report

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/benign-prostatic-hyperplasia-bph-treatment-devices-and-equipment-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: